Aggressively treating diabetes does not prevent heart problems and deaths any better than standard treatment for lowering blood sugar, Australian researchers reported recently.
Shares of Bristol-Myers Squibb Co. sank to their lowest level in almost six years Tuesday as analysts expressed concerns with side effects associated with the two of the company's experimental diabetes drugs.
Diabetes is the fifth-leading killer of Americans, according to the American Diabetes Association. A sobering two out of three people with type I or type II diabetes will die from a heart attack or stroke -- the combined leading causes of death among diabetics.
New research shows that insulin plays a key role in the brain -- and in the onset of Alzheimer's disease, prompting some researchers to call it "type 3" diabetes
As the nation's biggest diabetes conference wrapped up Tuesday, Bristol-Myers Squibb, AstraZeneca and Novo Nordisk emerged as drugmakers-to-watch with the most late-stage experimental diabetes drugs.
Bristol and AstraZeneca reported Monday the most advanced late-stage studies for their experimental drug saxagliptin, showing it helped diabetics control their blood-sugar levels.
Bristol-Myers Squibb and AstraZeneca are working on a new type of diabetes drug, and early-stage test results in humans have showed that the experimental drug, called dapagliflozin, could control blood-sugar levels in diabetics and appears to be safe.
Diabetics taking the blood-sugar drug Byetta had about one-sixth the risk of hypoglycemia compared to those taking insulin, according to study results from Byetta-makers Amylin and Lilly.
Aggressively treating diabetes does not prevent heart problems and deaths any better than standard treatment for lowering blood sugar, Australian researchers reported recently.
Shares of Bristol-Myers Squibb Co. sank to their lowest level in almost six years Tuesday as analysts expressed concerns with side effects associated with the two of the company's experimental diabetes drugs.
Diabetes is the fifth-leading killer of Americans, according to the American Diabetes Association. A sobering two out of three people with type I or type II diabetes will die from a heart attack or stroke -- the combined leading causes of death among diabetics.
New research shows that insulin plays a key role in the brain -- and in the onset of Alzheimer's disease, prompting some researchers to call it "type 3" diabetes
As the nation's biggest diabetes conference wrapped up Tuesday, Bristol-Myers Squibb, AstraZeneca and Novo Nordisk emerged as drugmakers-to-watch with the most late-stage experimental diabetes drugs.
Bristol and AstraZeneca reported Monday the most advanced late-stage studies for their experimental drug saxagliptin, showing it helped diabetics control their blood-sugar levels.
Bristol-Myers Squibb and AstraZeneca are working on a new type of diabetes drug, and early-stage test results in humans have showed that the experimental drug, called dapagliflozin, could control blood-sugar levels in diabetics and appears to be safe.
Diabetics taking the blood-sugar drug Byetta had about one-sixth the risk of hypoglycemia compared to those taking insulin, according to study results from Byetta-makers Amylin and Lilly.
Cholesterol-lowering statins - which include the world's top-selling drug, Lipitor - and other drugs called fibrates can lower the risk of developing a common form of nerve damage in diabetics that often results in amputations, according to study results unveiled Friday.
The controversy surrounding GlaxoSmithKline's diabetes drug Avandia mounted Wednesday as a medical expert prepared to tell lawmakers the British drug maker threatened him with legal action when he first raised questions about the treatment's safety
(CHICAGO)--Diabetic children who spent the most time glued to the TV had a tougher time controlling their blood sugar, according to a Norwegian study that illustrates yet another downside of too much television.The findings, based on a study of children with Type 1 diabetes, lend support to the American Academy of Pediatrics' advice that children watch no more than two hours of TV daily, said lead author Dr. Hanna Margeirsdottir of the University of Oslo.Type 1 diabetes is the less common form of the disease and used to be called juvenile diabetes. It is not related to obesity and is caused when the body cannot make insulin, which converts sugar from food into energy. People with Type 1 must take insulin daily and regulate their blood-sugar levels.Snacking and overeating can increase blood-sugar levels; physical activity can lower them. While TV-viewing is often accompanied by snacking, the researchers didn't examine diet or physical activity.The study results "suggest that encouraging children with Type
An experimental drug from Eli Lilly & Co. reduces the risk of vision loss in diabetics, who often suffer declining eyesight, according to studies released Sunday.
The use of antidepressants appears to increase the onset of diabetes in some high-risk individuals, according to a government-funded study announced Saturday.
A landmark finding a decade ago that sharply enhanced the lives of insulin-dependent diabetics now turns out to be much more beneficial than anyone suspected.
A new drug from Sanofi-Aventis is a weight loss pill and a diabetes treatment at the same time, and could treat millions of Americans if approved by the Food and Drug Administration. Separate studies have shown the drug may be effective at helping smokers quit the habit.
Merck and Bristol-Myers Squibb, both facing losses on two of their most profitable blockbusters, are partnering to try and launch a pill that has multiple uses in treating diabetes.
A new diabetes treatment from Eli Lilly and Amylin received approval from the Food and Drug Administration Friday, but analysts believe sales might be lackluster because of something most patients don't like: needles.
Americans have been giving generously to help victims of the tsunami disaster that destroyed seaside communities from Thailand to East Africa and killed 155,000 people.
When it comes to controlling insulin action in people with type 2 diabetes, it looks like some people might be able to trade in their running shoes for a pair of dumbbells.
Once you might have reasonably assumed that money you gave to a highly respected charity would be well spent. No longer. In February, the United Way of America, whose 2,100 chapters raised $3.1 bil...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the www.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
